US-headquartered biotech firm Cullgen snaps $40m in Series C round

US-headquartered biotech firm Cullgen snaps $40m in Series C round

Visual from Freedigitalphoto.net

09 May, 2023

Edited by: Joymitra Rai

AstraZeneca-CICC Venture Capital GNI Group Sincere Capital Voyagers Capital Wuxi Capital Group

Printed by Unregistered user on Wed, 30 Jul 2025 21:20:45 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

LinkedIn cuts over 700 jobs, shuts down China app as demand wavers

Venture Capital

China Digest: Rgenta Therapeutics, Taichu Biotech raise funding

Read more from Greater China

HongShan-backed RD Technologies snaps $40m in Series A2 round

HK-based SC Lowy closes $250m real estate financing deal in Seoul